Vassallo, V.; Di Meo, C.; Toro, G.; Alfano, A.; Iolascon, G.; Schiraldi, C.
Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429. Pharmaceuticals 2023, 16, 1685.
https://doi.org/10.3390/ph16121685
AMA Style
Vassallo V, Di Meo C, Toro G, Alfano A, Iolascon G, Schiraldi C.
Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429. Pharmaceuticals. 2023; 16(12):1685.
https://doi.org/10.3390/ph16121685
Chicago/Turabian Style
Vassallo, Valentina, Celeste Di Meo, Giuseppe Toro, Alberto Alfano, Giovanni Iolascon, and Chiara Schiraldi.
2023. "Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429" Pharmaceuticals 16, no. 12: 1685.
https://doi.org/10.3390/ph16121685
APA Style
Vassallo, V., Di Meo, C., Toro, G., Alfano, A., Iolascon, G., & Schiraldi, C.
(2023). Correction: Vassallo et al. Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins. Pharmaceuticals 2023, 16, 1429. Pharmaceuticals, 16(12), 1685.
https://doi.org/10.3390/ph16121685
